UNSPSC 51202601: Ascomycin

This classification denotes an immunosuppressant and a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AUF4U5NSJK, chemically known as (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-ethyl-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0?,?]octacos-18-ene-2,3,10,16-tetrone but more generally known as ascomycin, which bears US NIH Compound Identifier 5282071.

Most nations, for tariff and trade purposes, schedule ASCOMYCIN under HS 29349990 and SITC 51579. SMILES: CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C.

UNSPSC 51202601 Ascomycin, a Commodity code, shows minimal recent activity directly aligned with its nominal scope. State and local opportunities tagged under this code are actually soliciting naloxone, drug deactivation systems, medical and first aid supplies, and generic pharmaceuticals — products unrelated to ascomycin, an immunosuppressant topical agent. The mismatch suggests either systematic miscoding of health-related procurements or that ascomycin itself sees negligible state and local demand. Issuing bodies across the recent sample include county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance covering multiple states including Oregon). The actual work being purchased under this code tag ranges from emergency response consumables to pharmaceutical wholesale agreements, rather than ascomycin specifically.

Geographic activity spans Florida, Texas, Minnesota, and Oregon based on the recent solicitations, though the geographic spread reflects broad multi-state cooperative purchasing rather than concentrated regional demand for ascomycin. Representative recent opportunities include Seminole County's IFB60459723LAS (Naloxone & Drug Deactivation Systems, due July 26, 2026 with quarterly deliveries), the City of Tampa's 26P00145 (Medical and First Aid Supplies for the Fire Department, estimated contract value $700,000.00, SLBE-sheltered, due March 13, 2026), and MMCAP's S1070000015802 (Generic Multi Source Pharmaceuticals and OTC Products through authorized wholesalers, RFP due March 26, 2026, effective July 1, 2026). The Texas HHS Commission's RFI HHS0017013 (April 3, 2026) explores direct-to-manufacturer pharmacy programs but does not specify ascomycin. The code shows no meaningful pipeline for ascomycin procurement and should be deprioritized unless recoding patterns change.